Cover Image

Forensic chemistry of substance misuse : a guide to drug control /

Updating and expanding the coverage of the first Edition, this book provides a chemical background to domestic and international controls on substances of misuse. In the United Kingdom, structure-specific (generic) controls have been further developed in the past 13 years and now cover 17 groups of...

Full description

Bibliographic Details
Main Author: King, L. A. (Leslie A.) (Author)
Format: eBook
Language:English
Published: Cambridge : Royal Society of Chemistry, 2022.
Edition:Second edition.
Subjects:
Chemistry, Forensic.
Forensic pharmacology.
Drugs of abuse > Classification.
Drugs of abuse > Law and legislation.
Drugs of abuse.
Electronic books.
Classification.
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Halftitle
  • Title
  • Copyright
  • Dedication
  • Preface to the 2nd Edition
  • Preface
  • Acknowledgements
  • Coda: Beginnings
  • Glossary
  • Abbreviations
  • Chapter 1 Drug Misuse
  • 1.1 Introduction
  • 1.2 Drug Misuse in England and Wales
  • 1.2.1 Household Surveys of Drug Misuse
  • 1.2.2 Drug-associated Deaths
  • 1.2.3 Seizures by Law Enforcement Agencies
  • References
  • Chapter 2 International Drugs Control
  • 2.1 Introduction
  • 2.2 United Nations Single Convention on Narcotic Drugs, 1961
  • 2.3 United Nations Convention on Psychotropic Substances, 1971
  • 2.4 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988
  • 2.5 The Role of the European Union
  • 2.5.1 'Joint Action': The Period 1997 to 2005
  • 2.5.2 The EU Council Decision of 2005
  • 2.5.3 The Period since 2018
  • 2.6 Legislative Developments in Other Countries
  • References
  • Chapter 3 Primary UK Drugs Legislation up to 1971
  • 3.1 Drug Control in the UK before 1971
  • 3.2 The Misuse of Drugs Act 1971
  • 3.3 Offences and Penalties under the MDAct
  • 3.3.1 Cultivation of Cannabis
  • 3.3.2 Production of a Controlled Drug
  • 3.4 The Advisory Council on the Misuse of Drugs
  • 3.5 Reviews of the MDAct
  • 3.5.1 Review by the ACMD (1979)
  • 3.5.2 The Independent Enquiry into the MDAct (2000)
  • 3.5.3 Home Affairs Select Committee (2001-2)
  • 3.5.4 Select Committee on Science and Technology (2006)
  • 3.5.5 Royal Society of Arts Report (2007)
  • 3.5.6 Demos Report 'Taking Drugs Seriously' (2011)
  • 3.5.7 Home Affairs Select Committee (2012)
  • 3.5.8 All-Party Parliamentary Group for Drug Policy Reform (2013)
  • 3.5.9 Royal Society for Public Health (2016)
  • 3.5.10 Royal Society of Arts (2017)
  • 3.5.11 House of Commons Health and Social Care Committee: Drugs Policy (2019)
  • 3.5.12 Independent Review of Drugs by Dame Carol Black (2021)
  • 3.5.13 Problem Drugs Bill: A Private Members' Bill Tabled by Tommy Sheppard MP (2021)
  • 3.6 Substances Removed and/or Reinstated
  • 3.7 Cannabis: Classification and Reclassification
  • 3.8 The Classification of MDMA
  • 3.9 The Precautionary Principle
  • 3.10 Conclusions
  • References
  • Chapter 4 The Misuse of Drugs Regulations 2001
  • 4.1 Introduction
  • 4.2 Regulations Relevant to Forensic Science
  • 4.2.1 Exceptions for Drugs in Schedules 4 and 5 and Poppy Straw
  • 4.2.2 Exceptions for Drugs in Schedule 1
  • 4.2.3 Exceptions for Gamma-butyrolactone and 1,4-Butanediol
  • 4.3 The Impact of the MD Regulations on Scientific Research
  • References
  • Chapter 5 UK Drugs Legislation since 1971
  • 5.1 Drugs Act 2005
  • 5.2 Temporary Class Drug Orders
  • 5.3 Importation Controls
  • 5.4 The Psychoactive Substances Act 2016
  • 5.4.1 Alkyl Nitrites
  • 5.4.2 Nitrous Oxide
  • 5.4.3 Reviews of the Psychoactive Substances Act
  • 5.5 Other Drug-related Legislation in the UK
  • 5.5.1 Road Traffic Act 1972